FDA’s Guidance on the Use of Social Media in Regulated Companies
Speaker: Carolyn Troiano
Speaker Designation: FDA Compliance Consultant
Speaker: Carolyn Troiano
Speaker Designation: FDA Compliance Consultant
With the rapid expansion of social media usage, it has become imperative for companies in FDA-regulated industries to grasp the existing and upcoming regulations to meet compliance standards.
During this webinar, we will elucidate the FDA's current perspectives and the reasoning behind them. You will gain valuable knowledge on how to achieve compliance objectives in a cost-effective manner, empowering your organization to navigate the dynamic landscape of social media while adhering to regulatory requirements. Don't miss this opportunity to stay ahead in the ever-evolving world of FDA regulations and social media marketing!
The webinar delves into the application of the FDA's latest guidance on utilizing social media for presenting and promoting drug products and FDA-regulated medical devices. This session aims to equip you with comprehensive insights, enabling the development of effective strategies, policies, and procedures to ensure compliance.
If you work in FDA-regulated industries, such as pharmaceuticals, medical devices, biological products, tobacco, and tobacco-related products (e-liquids, cigars), this webinar is tailor-made for you. It caters to a wide range of functions within these industries, including marketing, regulatory affairs, compliance, sales, manufacturing, quality control, clinical study management, labeling, adverse events management, and post-marketing surveillance.
If your responsibilities involve planning, executing, or overseeing processes related to utilizing social media for posting product-related information, then this webinar is a must-attend event. It will provide valuable insights and guidance to enhance your understanding and proficiency in navigating the realm of social media within FDA regulations.
This webinar will provide valuable insight for:
Carolyn Troiano has more than 40 years of experience in computer systems and data in the pharmaceutical, medical device, tobacco, cannabis, and other FDA-regulated industries, as well as in banking, insurance, and government agencies. She is currently an independent consultant, advising companies on data integrity, privacy, and compliance, including implementing large-scale, complex systems, such as Enterprise Resource Planning (ERP), Customer Relationship Management (CRM), Clinical Trial Master File (TMF and eTMF), Manufacturing, Quality, and Enterprise Content Management (ECM) systems.